Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Biomed Mater ; 15(5): 055018, 2020 08 28.
Article in English | MEDLINE | ID: mdl-32438354

ABSTRACT

Tissue regeneration often requires the use of biocompatible resorbable scaffolds to support the ingrowth of cells from neighboring tissues into a localized tissue defect. Such scaffolds must possess surface molecular cues that stimulate cells to populate the device, the first necessary condition for the formation of a healthy tissue. Chitosan is a natural polymer that has long been tested in biomedical applications because of its high biocompatibility, which can be further increased by modifying its formulation, e.g. adding D-(+) raffinose. We used this formulation in an ad hoc designed 3D printer to create regularly ordered scaffolds, which we then enriched with type IV collagen, an isoform of collagen that is exclusively found in basement membranes. Human epithelial A549 cells were then seeded on control scaffolds or on scaffolds coated with collagen, which was precipitated, or on scaffolds first collagenized and then exposed to either UVB or UVC radiation. Observations by the transmission light microscope, confocal microscope after staining with calcein-AM/propidium iodide, and by environmental scanning electron microscope revealed that collagen-enriched UV-treated scaffolds promoted the attachment of a higher number of cells, which covered a more extensive area of the scaffold, as also confirmed by alamar blue viability assay. Together these data confirm that coating 3D-printed scaffolds made of D-(+) raffinose-modified chitosan with type IV collagen and exposing them to UV light sensibly increases the cell compatibility of scaffolds, making them a better candidate to serve as a tool for the regeneration of epithelia.


Subject(s)
Biocompatible Materials/chemistry , Chitosan/chemistry , Collagen Type IV/chemistry , Epithelial Cells/metabolism , Printing, Three-Dimensional , Raffinose/chemistry , Tissue Scaffolds/chemistry , A549 Cells , Cell Adhesion , Coated Materials, Biocompatible/chemistry , Collagen/chemistry , Fluoresceins/chemistry , Humans , Materials Testing , Microscopy, Confocal , Polymers/chemistry , Propidium/chemistry , Regeneration , Temperature , Tissue Engineering
2.
Oral Dis ; 26(6): 1185-1189, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32045089

ABSTRACT

Biological tissues (including oral mucosa) can absorb and re-emit specific light wavelengths, detectable through spectrophotometric devices. Such a phenomenon is known as "autofluorescence" (AF). Several devices evaluating tissue AF have been developed and commercialized in the last two decades. Among these, the VELscope® system has been proposed as a visual diagnostic aid for potentially malignant disorders and malignant lesions of the oral mucosa. In the present pilot study, we investigated which are the main histopathological features possibly related to variations in AF patterns in a set of 20 oral squamous cell verrucous carcinoma. Among all the histological features investigated, only the mean width of keratin was significantly different between hypofluorescent and hyperfluorescent carcinomas. The results of the present study demonstrate that AF features of oral malignant lesions are significantly associated with the width of their keratin layer.

3.
Pharmaceutics ; 11(9)2019 Sep 14.
Article in English | MEDLINE | ID: mdl-31540066

ABSTRACT

This paper addresses the problem of ocular delivery of lipophilic drugs. The aim of the paper is the evaluation of polymeric micelles, prepared using TPGS (d-α-Tocopheryl polyethylene glycol 1000 succinate), a water-soluble derivative of Vitamin E and/or poloxamer 407, as a vehicle for the ocular delivery of dexamethasone, cyclosporine, and econazole nitrate. The research steps were: (1) characterize polymeric micelles by dynamic light scattering (DLS) and X-ray scattering; (2) evaluate the solubility increase of the three drugs; (3) measure the in vitro transport and conjunctiva retention, in comparison to conventional vehicles; (4) investigate the mechanisms of enhancement, by studying drug release from the micelles and transconjunctival permeation of TPGS; and (5) study the effect of micelles application on the histology of conjunctiva. The data obtained demonstrate the application potential of polymeric micelles in ocular delivery, due to their ability to increase the solubility of lipophilic drugs and enhance transport in and across the conjunctival epithelium. The best-performing formulation was the one made of TPGS alone (micelles size ≈ 12 nm), probably because of the higher mobility of these micelles, an enhanced interaction with the conjunctival epithelium, and, possibly, the penetration of intact micelles.

4.
Med. oral patol. oral cir. bucal (Internet) ; 24(3): e339-e345, mayo 2019. tab, ilus
Article in English | IBECS | ID: ibc-185642

ABSTRACT

Background: The exact pathogenesis of medication-related osteonecrosis of the jaw (MRONJ) is still unknown. The aim of this paper was to investigate the effects of zoledronic acid and dexamethasone on the early phases of socket healing in rats subjected to tooth extractions. Material and Methods: Thirty male Sprague-Dawley rats were divided into 2 groups: pharmacologically treated group (T, n = 20) and non-pharmacologically treated group (C, n=10). T group rats received 0.1 mg/Kg of zoledronic acid (ZOL) and 1 mg/Kg of dexamethasone (DEX) three times a week for 10 consecutive weeks. C group rats were infused with vehicle. After 9 weeks from the first infusion, first maxillary molars were extracted in each of the rats. Quantitative macroscopic and microscopic analysis was performed to evaluate socket healing 8 days after extraction. Results: Pharmacologically treated rats showed significant inhibition of bone remodeling. Connective tissue/al-eolar bone ratio, osteoclast number and woven bone deposition were significantly reduced in group T compared to group C. Conversely, the proportion of necrotic bone was higher in group T compared to group C (0.8% and 0.3%, respectively. P = 0.031). ZOL plus DEX do not cause gross effects on socket healing at a macroscopic level. Conclusions: Our findings confirmed that exposure to ZOL plus DEX impairs alveolar wound repair. Inhibition of osteoclastic resorption of socket walls after tooth extraction and the inability to dispose of the necrotic bone may be considered the initial steps of MRONJ onset


No disponible


Subject(s)
Humans , Animals , Male , Rats , Bone Density Conservation Agents , Osteonecrosis , Dexamethasone , Diphosphonates , Tooth Extraction , Tooth Socket , Zoledronic Acid , Rats, Sprague-Dawley
5.
Carbohydr Polym ; 199: 593-602, 2018 Nov 01.
Article in English | MEDLINE | ID: mdl-30143167

ABSTRACT

The fabrication of porous 3D printed chitosan (CH) scaffolds for skin tissue regeneration and their behavior in terms of biocompatibility, cytocompatibility and toxicity toward human fibroblasts (Nhdf) and keratinocytes (HaCaT), are presented and discussed. 3D cell cultures achieved after 20 and 35 days of incubation showed significant in vitro qualitative and quantitative cell growth as measured by neutral red staining and MTT assays and confirmed by scanning electron microphotographs. The best cell growth was obtained after 35 days on 3D scaffolds when the Nhdf and HaCaT cells, seeded together, filled the pores in the scaffolds. An early skin-like layer consisting of a mass of fibroblast and keratinocyte cells growing together was observed. The tests of 3D printed scaffolds in wound healing carried out on streptozotocin-induced diabetic rats demonstrate that 3D printed scaffolds improve the quality of the restored tissue with respect to both commercial patch and spontaneous healing.


Subject(s)
Biocompatible Materials/therapeutic use , Chitosan/therapeutic use , Diabetes Mellitus, Experimental/metabolism , Printing, Three-Dimensional , Tissue Scaffolds/chemistry , Wound Healing/physiology , Animals , Bandages , Biocompatible Materials/chemistry , Biocompatible Materials/toxicity , Cell Line , Cell Survival/drug effects , Chitosan/chemistry , Chitosan/toxicity , Elastic Modulus , Female , Fibroblasts/drug effects , Humans , Keratinocytes/drug effects , Porosity , Rats, Wistar , Skin/drug effects , Wound Closure Techniques
6.
Int J Pharm ; 506(1-2): 420-8, 2016 Jun 15.
Article in English | MEDLINE | ID: mdl-27113869

ABSTRACT

Buccal administration of sumatriptan succinate might be an interesting alternative to the present administration routes, due to its non-invasiveness and rapid onset of action, but because of its low permeability, a permeation enhancement strategy is required. The aim of this work was then to study, in-vitro, buccal iontophoresis of sumatriptan succinate. Permeation experiments were performed in-vitro across pig esophageal epithelium, a recently proposed model of human buccal mucosa, using vertical diffusion cells. The iontophoretic behavior of the tissue was characterized by measuring its isoelectric point (Na(+) transport number and the electroosmotic flow of acetaminophen determination) and by evaluating tissue integrity after current application. The results obtained confirm the usefulness of pig esophageal epithelium as an in-vitro model membrane for buccal drug delivery. The application of iontophoresis increased sumatriptan transport, proportionally to the current density applied, without tissue damage: electrotransport was the predominant mechanism. Integrating the results of the present work with literature data on the transport of other molecules across the buccal mucosa and across the skin, we can draw a general conclusion: the difference in passive transport across buccal mucosa and across the skin is influenced by permeant lipophilicity and by the penetration pathway. Finally, buccal iontophoretic administration of sumatriptan allows to administer 6mg of the drug in 1h, representing a promising alternative to the current administration routes.


Subject(s)
Iontophoresis , Mouth Mucosa/metabolism , Serotonin 5-HT1 Receptor Agonists/administration & dosage , Sumatriptan/administration & dosage , Acetaminophen/pharmacokinetics , Administration, Buccal , Animals , Biological Transport , Drug Delivery Systems , Isoelectric Point , Models, Animal , Permeability , Serotonin 5-HT1 Receptor Agonists/pharmacokinetics , Skin Absorption , Sumatriptan/pharmacokinetics , Swine
7.
Support Care Cancer ; 24(2): 807-813, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26190360

ABSTRACT

PURPOSE: Laser therapy has been used for the prevention and management of medication-related ostenecrosis of the jaw (MRONJ). The aim of this paper was to investigate the action of laser therapy on extraction socket healing in rats in conditions at risk for MRONJ, evaluating the expression of markers of bone metabolism. METHODS: Thirty male Sprague-Dawley rats were divided in four groups: control group (C, n = 5), laser group (L, n = 5), treatment group (T, n = 10), and treatment plus laser group (T + L, n = 10). Rats of group T and T + L received zoledronate 0.1 mg/kg and dexamethasone 1 mg/kg every 2 days for 10 weeks. Rats of group C and L were infused with vehicle. After 9 weeks, the left maxillary molars were extracted in all rats. Rats of groups L and T + L received laser therapy (Nd:YAG, 1064 nm, 1.25 W, 15 Hz, 5 min, 14.37 J/cm(2)) in the socket area at days 0, 2, 4, and 6 after surgery. Western blot analysis was performed to evaluate the alveolar expression of osteopontin (OPN) and osteocalcin (OCN) 8 days after extraction. RESULTS: Rats of groups L and T + L showed a significant higher expression of OCN compared to rats of groups C and T (+348 and +400 %, respectively; P = 0.013 and P = 0.002, respectively). The expression of OPN did not show significant differences among the different groups. CONCLUSIONS: Our findings suggest that laser irradiation after tooth extraction can promote osteoblast differentiation, as demonstrated by the higher expression of OCN. Thus, laser irradiation could be considered a way to improve socket healing in conditions at risk for MRONJ development.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Bone Density Conservation Agents/pharmacology , Dexamethasone/pharmacology , Diphosphonates/pharmacology , Imidazoles/pharmacology , Low-Level Light Therapy/methods , Osteocalcin/metabolism , Osteonecrosis/prevention & control , Osteopontin/metabolism , Tooth Extraction , Tooth Socket , Wound Healing , Animals , Anti-Inflammatory Agents/administration & dosage , Bone Density Conservation Agents/administration & dosage , Combined Modality Therapy , Dexamethasone/administration & dosage , Diphosphonates/administration & dosage , Imidazoles/administration & dosage , Male , Rats , Rats, Sprague-Dawley , Zoledronic Acid
8.
Biomed Res Int ; 2015: 691693, 2015.
Article in English | MEDLINE | ID: mdl-26539521

ABSTRACT

RATIONALE: Heart failure (HF) is accompanied by the development of an imbalance between oxygen- and nitric oxide-derived free radical production leading to protein nitration. Both chlorinating and peroxidase cycle of Myeloperoxidase (MPO) contribute to oxidative and nitrosative stress and are involved in tyrosine nitration of protein. Ceruloplasmin (Cp) has antioxidant function through its ferroxidase I (FeOxI) activity and has recently been proposed as a physiological defense mechanism against MPO inappropriate actions. OBJECTIVE: We investigated the relationship between plasma MPO-related chlorinating activity, Cp and FeOxI, and nitrosative stress, inflammatory, neurohormonal, and nutritional biomarkers in HF patients. METHODS AND RESULTS: In chronic HF patients (n = 81, 76 ± 9 years, NYHA Class II (26); Class III (29); Class IV (26)) and age-matched controls (n = 17, 75 ± 11 years, CTR), plasma MPO chlorinating activity, Cp, FeOxI, nitrated protein, free Malondialdehyde, BNP, norepinephrine, hsCRP, albumin, and prealbumin were measured. Plasma MPO chlorinating activity, Cp, BNP, norepinephrine, and hsCRP were increased in HF versus CTR. FeOxI, albumin, and prealbumin were decreased in HF. MPO-related chlorinating activity was positively related to Cp (r = 0.363, P < 0.001), nitrated protein, hsCRP, and BNP and inversely to albumin. CONCLUSIONS: Plasma MPO chlorinated activity is increased in elderly chronic HF patients and positively associated with Cp, inflammatory, neurohormonal, and nitrosative parameters suggesting a role in HF progression.


Subject(s)
Biomarkers/blood , Ceruloplasmin/analysis , Heart Failure , Peroxidase/metabolism , Aged , Aged, 80 and over , Albumins/analysis , C-Reactive Protein/analysis , Chronic Disease/epidemiology , Cross-Sectional Studies , Female , Halogenation , Heart Failure/blood , Heart Failure/epidemiology , Heart Failure/metabolism , Heart Failure/physiopathology , Humans , Inflammation/blood , Inflammation/epidemiology , Inflammation/metabolism , Male , Natriuretic Peptide, Brain/blood
9.
J Pharm Sci ; 104(7): 2190-202, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25973792

ABSTRACT

Proteins and oligonucleotides represent powerful tools for the treatment of several ocular diseases, affecting both anterior and posterior eye segments. Despite the potential of these compounds, their administration remains a challenge. The last years have seen a growing interest for the noninvasive administration of macromolecular drugs, but still there is only little information of their permeability across the different ocular barriers. The aim of this work was to evaluate the permeation of macromolecules of different size, shape and charge across porcine ocular tissues such as the isolated sclera, the choroid Bruch's membrane and the cornea, both intact and de-epitelialized. Permeants used were two proteins (albumin and cytochrome C), an oligonucleotide, two dextrans (4 and 40 kDa) and a monoclonal antibody (bevacizumab). Obtained data and its comparison with the literature highlight the difficulties in predicting the behavior of macromolecules based on their physicochemical properties, because the interplay between the charge, molecular radius and conformation prevent their analysis separately. However, the data can be of great help for a rough evaluation of the feasibility of a noninvasive administration and for building computational models to improve understanding of the interplay among static, dynamic and metabolic barriers in the delivery of macromolecules to the eye.


Subject(s)
Choroid/metabolism , Cornea/metabolism , Dextrans/metabolism , Oligonucleotides/metabolism , Proteins/metabolism , Sclera/metabolism , Animals , Bevacizumab/metabolism , Biological Transport/physiology , Diffusion , Female , Male , Permeability , Swine
10.
Histol Histopathol ; 30(1): 69-76, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25046102

ABSTRACT

The role of angiogenesis as a hallmark of tumor progression has been poorly explored in leiomyosarcoma, a rare but aggressive mesenchymal malignancy. We aimed to characterize microvessel distribution and morphology - including pericyte coverage - in a retrospective series of leyomiosarcomas of the soft tissues and the uterus. 41 whole-block tumor slides from formalin-fixed paraffin-embedded tissues were immunostained for endothelial-specific marker CD31 and microvessel density was quantified by assigning a grade to the frequency of CD31 positive microvessels. Vessel morphology and pericyte coverage were investigated by double-labeling for CD31 and either PDGFRß, αSMA, desmin, CD90, or CD146. We found that microvessel density correlated with tumor grade in leiomyosarcoma of soft tissues, in analogy with what has been established in several types of carcinoma. This did not apply to uterine leiomyosarcoma, possibly due to the abundant myometrial vascularization. The evaluation of perivascular cell markers related to vessel stability revealed immature microvascular networks with aberrant pericyte coverage, irrespective of tumor origin or grade. Our observations substantiate the role of angiogenesis in the progression of soft tissue leiomyosarcoma. A multiple-marker approach to the assessment of pericyte coverage can identify different profiles of vessel immaturity correlated with tumor grade.


Subject(s)
Biomarkers, Tumor/metabolism , Leiomyosarcoma/metabolism , Neovascularization, Pathologic/metabolism , Soft Tissue Neoplasms/metabolism , Uterine Neoplasms/metabolism , Adult , Aged , Aged, 80 and over , Antigens, CD/metabolism , Female , Humans , Male , Microcirculation , Middle Aged , Neovascularization, Pathologic/pathology , Pericytes/metabolism , Pericytes/pathology , Prognosis , Retrospective Studies , Soft Tissue Neoplasms/pathology , Uterine Neoplasms/pathology
11.
J Pharm Sci ; 104(1): 63-71, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25394188

ABSTRACT

In this paper, an ex vivo model for the study of the transcorneal permeation of drugs, based on porcine tissues, was evaluated. The setup is characterized by ease of realization, absence of O2 and CO2 bubbling and low cost; additionally, the large availability of porcine tissue permits a high throughput. Histological images showed the comparability between porcine and human corneas and confirmed the effectiveness of the isolation procedure. A new de-epithelization procedure based on a thermal approach was also set up to simulate cornea permeability in pathological conditions. The procedure did not affect the integrity of the underlying layers and allowed the characterization of the barrier properties of epithelium and stroma. Six compounds with different physicochemical properties were tested: fluorescein, atenolol, propranolol, diclofenac, ganciclovir and lidocaine. The model highlighted the barrier function played by epithelium toward the diffusion of hydrophilic compounds and the permselectivity with regard to more lipophilic molecules. In particular, positively charged compounds showed a significantly higher transcorneal permeability than negatively charged compounds. The comparability of results with literature data supports the goodness and the robustness of the model, especially taking into account the behavior of fluorescein, which is generally considered a marker of tissue integrity.


Subject(s)
Cornea/metabolism , Drug Evaluation, Preclinical/methods , Drugs, Investigational/metabolism , High-Throughput Screening Assays , Models, Biological , Ocular Absorption , Abattoirs , Administration, Ophthalmic , Animals , Chemical Phenomena , Cornea/cytology , Corneal Stroma/cytology , Corneal Stroma/metabolism , Drugs, Investigational/administration & dosage , Drugs, Investigational/analysis , Drugs, Investigational/chemistry , Epithelium, Corneal/physiology , Humans , Hydrophobic and Hydrophilic Interactions , In Vitro Techniques , Kinetics , Permeability , Species Specificity , Sus scrofa
12.
Drug Des Devel Ther ; 8: 745-57, 2014.
Article in English | MEDLINE | ID: mdl-24959069

ABSTRACT

BACKGROUND: Mapracorat, a novel nonsteroidal selective glucocorticoid receptor agonist, has been proposed for the topical treatment of inflammatory disorders as it binds with high affinity and selectivity to the human glucocorticoid receptor and displays a potent anti-inflammatory activity, but seems to be less effective in transactivation of a number of genes, resulting in a lower potential for side effects. Contrary to classical glucocorticoids, mapracorat displays a reduced ability to increase intraocular pressure and in inducing myocilin, a protein linked to intraocular pressure elevation. Allergic conjunctivitis is the most common form of ocular allergy and can be divided into an early phase, developing immediately after allergen exposure and driven primarily by mast cell degranulation, and a late phase, developing from 6-10 hours after the antigen challenge, and characterized by conjunctival infiltration of eosinophils and other immune cells as well as by the production of cytokines and chemokines. METHODS: In this study, mapracorat was administered into the conjunctival sac of ovalbumin (OVA)-sensitized guinea pigs 2 hours after the induction of allergic conjunctivitis, with the aim of investigating its activity in reducing clinical signs of the late-phase ocular reaction and to determine its mechanism of anti-allergic effects with respect to apoptosis of conjunctival eosinophils and expression of the chemokines C-C motif ligand 5 (CCL5), C-C motif ligand 11 (CCL11), and interleukin-8 (IL-8) and the proinflammatory cytokines interleukin-1ß (IL-1ß) and tumor necrosis factor-α (TNF-α). RESULTS: Mapracorat, administered into the conjunctival sac of OVA-sensitized guinea pigs 2 hours after allergen exposure, was effective in reducing clinical signs, eosinophil infiltration, and eosinophil peroxidase activity in the guinea pig conjunctiva; furthermore, it reduced conjunctival mRNA levels and protein expression of both CCL5 and CCL11. Mapracorat was more effective than dexamethasone in increasing, in conjunctival sections of OVA-treated guinea pigs, apoptotic eosinophils. CONCLUSION: Mapracorat displays anti-allergic properties in controlling the late phase of ocular allergic conjunctivitis and is a promising candidate for the topical treatment of allergic eye disorders.


Subject(s)
Apoptosis/drug effects , Benzofurans/pharmacology , Conjunctiva/drug effects , Conjunctivitis, Allergic/drug therapy , Eosinophils/drug effects , Pentanols/pharmacology , Quinolines/pharmacology , Receptors, Glucocorticoid/agonists , Animals , Benzofurans/administration & dosage , Benzofurans/therapeutic use , Conjunctiva/immunology , Conjunctiva/pathology , Conjunctivitis, Allergic/immunology , Conjunctivitis, Allergic/pathology , Eosinophils/immunology , Eosinophils/pathology , Guinea Pigs , Humans , Male , Molecular Conformation , Pentanols/administration & dosage , Pentanols/therapeutic use , Quinolines/administration & dosage , Quinolines/therapeutic use , Structure-Activity Relationship
13.
Circ Res ; 114(11): 1723-32, 2014 May 23.
Article in English | MEDLINE | ID: mdl-24687133

ABSTRACT

RATIONALE: Ceruloplasmin antioxidant function is mainly related to its ferroxidase I (FeOxI) activity, which influences iron-dependent oxidative and nitrosative radical species generation. Peroxynitrite, whose production is increased in heart failure (HF), can affect ceruloplasmin antioxidant function through amino acid modification. OBJECTIVE: We investigated the relationship between FeOxI and ceruloplasmin tyrosine and cysteine modification and explored in a cohort of patients with HF the potential clinical relevance of serum FeOxI. METHODS AND RESULTS: In patients with chronic HF (n=96, 76 ± 9 years; New York Heart Association class, 2.9 ± 0.8) and age-matched controls (n=35), serum FeOxI, FeOxII, ceruloplasmin, nitrotyrosine-bound ceruloplasmin, B-type natriuretic peptide, norepinephrine, and high-sensitivity C-reactive protein were measured, and the patients were followed up for 24 months. Ceruloplasmin, B-type natriuretic peptide, norepinephrine, and high-sensitivity C-reactive protein were increased in HF versus controls. FeOxI was decreased in HF (-20%) and inversely related to nitrotyrosine-bound ceruloplasmin (r, -0.305; P=0.003). In HF, FeOxI lower tertile had a mortality rate doubled compared with middle-higher tertiles. FeOxI emerged as a mortality predictor (hazard ratio, 2.95; 95% confidence intervals [1.29-6.75]; P=0.011) after adjustment for age, sex, hypertension, smoking, sodium level, estimated glomerular filtration rate, and high-sensitivity C-reactive protein. In experimental settings, peroxynitrite incubation of serum samples and isolated purified ceruloplasmin reduced FeOxI activity while increasing ceruloplasmin tyrosine nitration and cysteine thiol oxidation. Reduced glutathione prevented peroxynitrite-induced FeOxI drop, tyrosine nitration, and cysteine oxidation; flavonoid(-)-epicatechin, which prevented ceruloplasmin tyrosine nitration but not cysteine oxidation, partially impeded peroxynitrite-induced FeOxI drop. CONCLUSIONS: Reduced activity of serum FeOxI is associated with ceruloplasmin nitration and reduced survival in patients with HF. Both ceruloplasmin tyrosine nitration and cysteine thiol oxidation may be operant in vivo in peroxynitrite-induced FeOxI activity inhibition.


Subject(s)
Ceruloplasmin/metabolism , Cysteine/metabolism , Heart Failure/metabolism , Heart Failure/mortality , Peroxynitrous Acid/metabolism , Tyrosine/metabolism , Aged , Aged, 80 and over , Biomarkers/metabolism , C-Reactive Protein/metabolism , Case-Control Studies , Cohort Studies , Female , Follow-Up Studies , Heart Failure/diagnosis , Humans , Male , Natriuretic Peptide, Brain/metabolism , Norepinephrine/metabolism , Oxidation-Reduction , Prognosis , Proportional Hazards Models , Survival Rate
14.
Psychoneuroendocrinology ; 38(12): 2933-42, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24060458

ABSTRACT

Stress and hypercaloric food are recognized risk factors for obesity, Metabolic Syndrome (MetS) and Type 2 Diabetes (T2D). Given the complexity of these metabolic processes and the unavailability of animal models, there is poor understanding of their underlying mechanisms. We established a model of chronic psychosocial stress in which subordinate mice are vulnerable to weight gain while dominant mice are resilient. Subordinate mice fed a standard diet showed marked hyperphagia, high leptin, low adiponectin, and dyslipidemia. Despite these molecular signatures of MetS and T2D, subordinate mice fed a standard diet were still euglycemic. We hypothesized that stress predisposes subordinate mice to develop T2D when synergizing with other risk factors. High fat diet aggravated dyslipidemia and the MetS thus causing a pre-diabetes-like state in subordinate mice. Contrary to subordinates, dominant mice were fully protected from stress-induced metabolic disorders when fed both a standard- and a high fat-diet. Dominant mice showed a hyperphagic response that was similar to subordinate but, unlike subordinates, showed a significant increase in VO2, VCO2, and respiratory exchange ratio when compared to control mice. Overall, we demonstrated a robust stress- and social status-dependent effect on the development of MetS and T2D and provided insights on the physiological mechanisms. Our results are reminiscent of the effect of the individual socioeconomic status on human health and provide an animal model to study the underlying molecular mechanisms.


Subject(s)
Hyperphagia/psychology , Insulin Resistance , Metabolic Syndrome/metabolism , Metabolic Syndrome/psychology , Social Environment , Stress, Psychological/psychology , Adiponectin/metabolism , Animals , Calorimetry, Indirect , Diabetes Mellitus, Type 2/blood , Diet , Diet, High-Fat , Energy Intake , Energy Metabolism , Glucose Tolerance Test , Hyperphagia/etiology , Immunohistochemistry , Leptin/blood , Male , Mice , Risk Factors , Social Dominance , Stress, Psychological/complications
15.
Nephrol Dial Transplant ; 27(10): 3875-84, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23114905

ABSTRACT

BACKGROUND: Idiopathic retroperitoneal fibrosis (IRF) is a rare fibro-inflammatory disorder characterized by a periaortic tissue which often encases the ureters causing acute renal failure. IRF histology shows fibrosis and a chronic inflammatory infiltrate with frequent tissue eosinophilia. We assessed a panel of molecules promoting eosinophilia and fibrosis in IRF patients and performed an immunogenetic study. METHODS: Serum levels of eotaxin/CCL11, regulated and normal T-cell expressed and secreted (RANTES), granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-5, platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) were measured using a multiplex assay in 24 newly diagnosed, untreated IRF patients and 14 healthy controls. Retroperitoneal biopsies (available in 8/24 patients) were histologically evaluated to assess eosinophil infiltration, whereas mast cells (MCs) were identified by immunohistochemical analysis for human tryptase. Immunohistochemistry for eotaxin/CCL11 and its receptor CCR3 was also performed. Six single nucleotide polymorphisms (SNPs) within the CCL11 gene (rs6505403, rs1860184, rs4795896, rs17735961, rs16969415 and rs17809012) were investigated in 142 IRF patients and 214 healthy controls. RESULTS: Serum levels of eotaxin/CCL11 were higher in IRF patients than in controls (P = 0.009). Eotaxin/CCL11 drives tissue infiltration of eosinophils and MCs, which can promote fibrosis. Eosinophilic infiltration was prominent (>5 cells/hpf) in five (62.5%) cases, and abundant tryptase-positive MCs were found in all cases; notably, MCs were in a degranulating state. Immunohistochemistry showed that CCL11 was highly produced by infiltrating mononuclear cells and that its receptor CCR3 was expressed by infiltrating eosinophils, MCs, lymphocytes and fibroblasts. None of the tested CCL11 SNPs showed disease association, but the TTCCAT haplotype was significantly associated with IRF (P = 0.0005). CONCLUSIONS: These findings suggest that the eotaxin/CCL11-CCR3 axis is active in IRF and may contribute to its pathogenesis; the TTCCAT haplotype within the CCL11 gene is significantly associated with IRF.


Subject(s)
Chemokine CCL11/metabolism , Retroperitoneal Fibrosis/immunology , Becaplermin , Case-Control Studies , Chemokine CCL11/blood , Chemokine CCL11/genetics , Chemokine CCL5/blood , Eosinophils/pathology , Female , Fibroblast Growth Factor 2/blood , Genetic Association Studies , Granulocyte Colony-Stimulating Factor/blood , Haplotypes , Humans , Immunogenetic Phenomena , Interleukin-5/blood , Male , Mast Cells/pathology , Middle Aged , Polymorphism, Single Nucleotide , Proto-Oncogene Proteins c-sis/blood , Receptors, CCR3/metabolism , Retroperitoneal Fibrosis/genetics , Retroperitoneal Fibrosis/pathology
16.
Eur J Pharm Sci ; 46(5): 475-83, 2012 Aug 15.
Article in English | MEDLINE | ID: mdl-22484210

ABSTRACT

Trans-scleral delivery is nowadays considered as a possible way to deliver drugs to the posterior segment of the eye. Despite the potentiality of this administration route, there is a lack of fundamental knowledge on the role of the numerous barriers involved. The aim of this work was to develop an easy and cheap ex vivo method to evaluate the barrier properties of the choroid-Bruch's layer and in particular to estimate the role of melanin in drug diffusion through ocular tissues. In vitro binding studies were performed to estimate drug affinity for melanin; model molecules used were methylene blue, propranolol, levofloxacin and methylprednisolone sodium succinate. The ex vivo model set up is based on porcine eye bulbs with light blue iris or brown iris. While the choroid of brown eyes is dark, the choroid of blue eyes is transparent, due to the absence of melanin. Permeation experiments using pigmented and not-pigmented porcine tissues gave the opportunity to discriminate between the barrier role of choroid-Bruch's membrane as such and the barrier role of melanin. Ex vivo permeation experiments can be performed using isolated choroid-Bruch's or the sclera-choroid-Bruch's layer. In this last case, it is possible to take into account also the barrier role of the sclera that tends to decrease the drug concentration at the sclera/choroid interface, thus amplifying the effect of melanin. The data obtained in this paper indicate that for some drugs melanin can really represent a barrier and the effect can imply a lower drug flux or simply a longer lag time depending on the kind of drug and the concentration applied. However, it is a saturable barrier, thus its effect can probably be overtaken by high doses or multiple administrations. The ex vivo model set up can help to refine computational models, to better evaluate the interplay among static, dynamic and metabolic barriers. Additionally, since human eyes display a full range of pigmentation, the model could also be useful to investigate the possible influence of pigmentation phenotype on trans-scleral delivery.


Subject(s)
Bruch Membrane/metabolism , Choroid/metabolism , Eye Color , Melanins/metabolism , Pharmaceutical Preparations/administration & dosage , Pharmaceutical Preparations/metabolism , Sclera/metabolism , Administration, Ophthalmic , Animals , Binding Sites , Diffusion , In Vitro Techniques , Levofloxacin , Methylene Blue/administration & dosage , Methylene Blue/metabolism , Methylprednisolone Hemisuccinate/administration & dosage , Methylprednisolone Hemisuccinate/metabolism , Ofloxacin/administration & dosage , Ofloxacin/metabolism , Permeability , Propranolol/administration & dosage , Propranolol/metabolism , Swine
17.
Biochem J ; 441(1): 511-22, 2012 Jan 01.
Article in English | MEDLINE | ID: mdl-21880012

ABSTRACT

The peptides encoded by the VGF gene are gaining biomedical interest and are increasingly being scrutinized as biomarkers for human disease. An endocrine/neuromodulatory role for VGF peptides has been suggested but never demonstrated. Furthermore, no study has demonstrated so far the existence of a receptor-mediated mechanism for any VGF peptide. In the present study, we provide a comprehensive in vitro, ex vivo and in vivo identification of a novel pro-lipolytic pathway mediated by the TLQP-21 peptide. We show for the first time that VGF-immunoreactivity is present within sympathetic fibres in the WAT (white adipose tissue) but not in the adipocytes. Furthermore, we identified a saturable receptor-binding activity for the TLQP-21 peptide. The maximum binding capacity for TLQP-21 was higher in the WAT as compared with other tissues, and selectively up-regulated in the adipose tissue of obese mice. TLQP-21 increases lipolysis in murine adipocytes via a mechanism encompassing the activation of noradrenaline/ß-adrenergic receptors pathways and dose-dependently decreases adipocytes diameters in two models of obesity. In conclusion, we demonstrated a novel and previously uncharacterized peripheral lipolytic pathway encompassing the VGF peptide TLQP-21. Targeting the sympathetic nerve-adipocytes interaction might prove to be a novel approach for the treatment of obesity-associated metabolic complications.


Subject(s)
Neuropeptides/metabolism , Peptide Fragments/pharmacology , Adipocytes/cytology , Adipocytes/drug effects , Animals , Body Composition , Dietary Fats/adverse effects , Dietary Fats/metabolism , Male , Mice , NIH 3T3 Cells , Nerve Growth Factors , Obesity/chemically induced , Obesity/metabolism , Protein Binding , Protein Transport , Receptors, Cell Surface
18.
Mol Vis ; 17: 3208-23, 2011.
Article in English | MEDLINE | ID: mdl-22194647

ABSTRACT

PURPOSE: Glucocorticoids can either suppress gene transcription (transrepression) or activate it (transactivation). This latter process may contribute to certain side effects caused by these agents. Mapracorat (also known as BOL-303242-X or ZK 245186) is a novel selective glucocorticoid receptor agonist that maintains a beneficial anti-inflammatory activity but seems to be less effective in transactivation, resulting in a lower potential for side effects; it has been proposed for the topical treatment of inflammatory skin disorders. This study assessed the anti-allergic activity of mapracorat at the ocular level and whether eosinophils and mast cells are targets of its action. METHODS: With in vitro studies apoptosis was evaluated in human eosinophils by flow cytometry and western blot of caspase-3 fragments. Eosinophil migration toward platelet-activating factor was evaluated by transwell assays. Interleukin (IL)-6, IL-8, tumor necrosis factor-α (TNF-α), and the chemokine (C-C motif) ligand 5 (CCL5)/regulated upon activation normal T cell expressed, and presumably secreted (RANTES) were measured using a high-throughput multiplex luminex technology. Annexin I and the chemochine receptor C-X-C chemokine receptor 4 (CXCR4) were detected by flow cytometry. With in vivo studies, allergic conjunctivitis was induced in guinea pigs sensitized to ovalbumin by an ocular allergen challenge and evaluated by a clinical score. Conjunctival eosinophils were determined by microscopy or eosinophil peroxidase assay. RESULTS: In cultured human eosinophils, mapracorat showed the same potency as dexamethasone but displayed higher efficacy in increasing spontaneous apoptosis and in counteracting cytokine-sustained eosinophil survival. These effects were prevented by the glucocorticoid receptor antagonist mifepristone. Mapracorat inhibited eosinophil migration and IL-8 release from eosinophils or the release of IL-6, IL-8, CCL5/RANTES, and TNF-α from a human mast cell line with equal potency as dexamethasone, whereas it was clearly less potent than this glucocorticoid in inducing annexin I and CXCR4 expression on the human eosinophil surface; this was taken as a possible sign of glucocorticoid-dependent transactivation. In the guinea pig, mapracorat or dexamethasone eye drops induced an analogous reduction in clinical symptoms of allergic conjunctivitis and conjunctival eosinophil accumulation. CONCLUSIONS: Mapracorat appears to be a promising candidate for the topical treatment of allergic eye disorders. It maintains an anti-allergic profile similar to that of dexamethasone but seems to have fewer transactivation effects in comparison to this classical glucocorticoid. Some of its cellular targets may contribute to eosinophil apoptosis and/or to preventing their recruitment and activation and to inhibiting the release of cytokines and chemokines.


Subject(s)
Anti-Allergic Agents/administration & dosage , Benzofurans/administration & dosage , Conjunctiva/drug effects , Conjunctivitis, Allergic/drug therapy , Eosinophils/drug effects , Pentanols/administration & dosage , Quinolines/administration & dosage , Receptors, Glucocorticoid/agonists , Administration, Ophthalmic , Animals , Annexin A1/analysis , Anti-Allergic Agents/therapeutic use , Apoptosis/drug effects , Benzofurans/therapeutic use , Blotting, Western , Caspase 3/analysis , Caspase 3/biosynthesis , Cells, Cultured , Conjunctiva/immunology , Conjunctiva/pathology , Conjunctivitis, Allergic/chemically induced , Conjunctivitis, Allergic/immunology , Cytokines/biosynthesis , Cytokines/immunology , Dexamethasone/administration & dosage , Dexamethasone/therapeutic use , Eosinophils/immunology , Eosinophils/metabolism , Flow Cytometry , Guinea Pigs , Humans , Male , Mifepristone/pharmacology , Ophthalmic Solutions/administration & dosage , Ophthalmic Solutions/therapeutic use , Ovalbumin/adverse effects , Pentanols/therapeutic use , Quinolines/therapeutic use , Receptors, Glucocorticoid/antagonists & inhibitors , Receptors, Glucocorticoid/metabolism
19.
J Ethnopharmacol ; 137(1): 880-5, 2011 Sep 01.
Article in English | MEDLINE | ID: mdl-21771653

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Rosa canina L. is a medicinal plant largely used in traditional folk medicine. Several compounds from rose hip extracts were reported to display in vitro anti-inflammatory activities. AIM OF THE STUDY: The in vivo effects of Rosa canina extracts are still poorly investigated. In the present study the anti-inflammatory and the gastroprotective effects of a hydroalcoholic crude extract of Rosa canina fruits were tested in rat. MATERIALS AND METHODS: The anti-inflammatory activity of the extract was tested on the carrageenin-induced rat paw edema assay. The gastroprotective effect was investigated on the ethanol-induced gastric damage model. The in vitro antioxidant activity of this extract was also quantified using the Briggs-Rauscher oscillating reaction, the Trolox Equivalent Antioxidant Capacity method, and the Total Phenolic Content. RESULTS: Data show that the Rosa canina extract inhibits the development of carrageenin-induced edema; the anti-inflammatory power is similar to that of indomethacin. The antiedema effect was more significant using a higher dose of the extract. The total score expressing gastric damage was lower in Rosa canina pre-treated stomachs with respect to unpre-treated ones, although the antiulcerogenic effectiveness was not statistically significant. The antiulcerogenic effectiveness was not statistically detectable, even if the total score expressing gastric damage was lower in Rosa canina stomachs from pre-treated rats with respect to unpre-treated ones. Chemical analysis revealed that the extract owns a good antioxidant activity that may also contribute to the anti-inflammatory effects observed in vivo. CONCLUSIONS: Altogether, the present data demonstrate the anti-inflammatory property of Rosa canina suggesting its potential role as adjuvant therapeutic tool for the management of inflammatory-related diseases.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Inflammation/prevention & control , Plant Extracts/pharmacology , Rosa , Stomach Ulcer/prevention & control , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/isolation & purification , Antioxidants/chemistry , Antioxidants/isolation & purification , Carrageenan , Disease Models, Animal , Dose-Response Relationship, Drug , Ethanol , Fruit , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Inflammation/chemically induced , Male , Medicine, Traditional , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plants, Medicinal , Rats , Rats, Sprague-Dawley , Rosa/chemistry , Stomach Ulcer/chemically induced , Stomach Ulcer/pathology , Time Factors
20.
J Med Food ; 14(5): 499-504, 2011 May.
Article in English | MEDLINE | ID: mdl-21314364

ABSTRACT

Laurus nobilis L. (Family Lauraceae) is an evergreen tree widely distributed in the Mediterranean area and Europe. It is used in folk medicine of different countries as a stomachic and carminative as well as in treatment of gastric diseases. Extracts obtained with different methods (methanol and chloroform) from laurel leaves were evaluated for their gastroprotective activities in the rat. The antioxidant capacity of the different extracts has been also measured in vitro. In order to confirm the activities investigated, histological observations were performed. The gastric damage was significantly reduced by all extracts administered. The more effective protection was produced by chloroformic and methanolic crude extracts. The results obtained after oral administration of L. nobilis leaf extracts are in good agreement with their antioxidant capacity, confirming the relationship between pharmacological efficacy and antiradical activity. Histological evidences confirm the results evaluated with the animal procedures.


Subject(s)
Anti-Ulcer Agents/pharmacology , Antioxidants/pharmacology , Laurus/chemistry , Plant Extracts/pharmacology , Plant Leaves/chemistry , Stomach Ulcer/drug therapy , Administration, Oral , Animals , Male , Rats , Rats, Sprague-Dawley , Specimen Handling , Stomach Ulcer/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...